How is patient response to pathogens impacted by various health factors? Expert Dr. Rodney Rohde discusses the impact of some comorbidities and health conditions on infectious diseases.

Diversity in clinical trials benefits everyone in ways that cannot be overlooked. Here’s a look at some of the history that has led to distrust, the importance of clinical trial diversity, creating lifelines for marginalized patients, and helping patients to access tomorrow’s medicine today.

Decentralized clinical trials offer many advantages over traditional clinical trial models, but what are DCTs exactly? Here’s a look at clinical trials and BIPOC patients, DCTs, and what decentralized clinical trials can mean for BIPOC patients. 

Diversity in clinical trials has been a topic of interest at Diverse Health Hub (DHH). Increasing diversity in clinical trials helps investigators to further improve and refine treatments for underrepresented patient groups. Here’s a look at U.S. efforts for improvements in enhancing clinical trial diversity.

What have researchers learned about ancestry and the prevalence of cancer-associated genetic alterations? Here’s a look at some recent findings from the AACR Cancer Disparities Progress Report 2022.